.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Harvard Business School
Fuji
Cantor Fitzgerald
Citi
Federal Trade Commission
US Army
Chinese Patent Office
Deloitte
Fish and Richardson

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 085466

« Back to Dashboard
NDA 085466 describes BROMPHENIRAMINE MALEATE, which is a drug marketed by Pioneer Pharms, Par Pharm, Upsher-smith Labs, Pharm Assoc, Watson Labs, Alpharma Us Pharms, Vitarine, Ivax Sub Teva Pharms, Usl Pharma, Kv Pharm, Barr, Newtron Pharms, Nexgen Pharma Inc, Taro Pharm, Vintage Pharms, Acella Pharms Llc, and Paddock Llc, and is included in twenty NDAs. Additional details are available on the BROMPHENIRAMINE MALEATE profile page.

The generic ingredient in BROMPHENIRAMINE MALEATE is brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride. There are twenty-one drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride profile page.

Summary for NDA: 085466

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:ELIXIR;ORALStrength2MG/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
US Department of Justice
US Army
Merck
Teva
Fuji
Cerilliant
Novartis
Medtronic
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot